Main Article Content
PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.
2. Costello AM, Osrin D. Micronutrient status during pregnancy and outcomes for newborn infants in developing countries. J Nut 2003;133:1757-64.
3. Ayoubi JM, Hirt R, Badiou W, Hininger-Favier I et al. Nutrition et femme enceinte. J Gynecol Obstet 2012;5:1-14.
4. Cabrol D, Pons JC, Goffinet JF. Traité d'obstétrique. Paris, Flammarion, Médecine-Sciences;2003.
5. Geyl C, Subtil D, Vaast P, Coulon C et al. Interprétation des valeurs atypiques des marqueurs sériques. J Gynecol Obstet Biol Reprod 2014;43:5-11.
6. Gordon JD, Speroff L. Handbook for clinical gynecologic endocrinology and infertility. Lippincott Williams & Wilkins; 2002.
7. Mobasheri E, Keshtkar A, Golalipour MJ. Maternal folate and vitamin B12 status and neural tube defects in Northern Iran: a case control study. Iran J pediatr 2010;20:167-73.
8. Dugoff L, Hobbins JC, Malone FD, Porter TF et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Ggynecol 2004;191:1446-51.
9. Rissanen A, Niemimaa M, Suonpää M, Ryynänen M et al. Pregnancy-associated plasma protein A, free human chorionic gonadotrophin and nuchal translucency as predictors of miscarriage. Clin Genet 2006;69:287-9.
10. Yaron Y, OchshornY, Heifetz S, Lehavi O et al. First trimester maternal serum free human chorionic gonadotropin as a predictor of adverse pregnancy outcome. Fetal diagn ther 2002;17:352-6.
11. Bick DP, McCorkle D, Stanley WS, Stern HJ et al. Prenatal diagnosis of Smith-Lemli-Opitz syndrome in a pregnancy with low maternal serum oestriol and a sex-reversed fetus. Prenat Diagn 1999;19:68-71.
12. Keren DF, Canick JA, Johnson MZ, Schaldenbrand JD et al. Low maternal serum unconjugated estriol during prenatal screening as an indication of placental steroid sulfatase deficiency and X-linked ichthyosis. Am J Clin Pathol 1995;103:400-3.
13. Weissgerber TL, Wolfe LA. Physiological adaptation in early human pregnancy: adaptation to balance maternal-fetal demands. Appl physiol Nutr Metab 2006;31:1-11.
14. Cunningham DS, Brodnik RM, Rayl DL, Brown AW et al. Suboptimal progesterone production in pathologic pregnancies. J Reprod Med 1993; 38:301-5.
15. Daily CA, Laurent SL, Nunley WC. The prognostic value of serum progesterone and quantitative beta-human chorionic gonadotropin in early human pregnancy. Am J Obstet Gynecol 1994;171:380-3.
16. Muller F, Dreux S, Sault C, Galland A et al. Very low alpha-fetoprotein in down syndrome maternal serum screening. Prenat Diagn 2003; 23:584-7.
17. Cuckle H. Biochemical screening for Down syndrome. Eur J Obstet Gynecol Reprod Biol 2000; 92: 97-101.
18. Milunsky A, Jick SS, Bruell CL, MacLaughlin DS et al. Predictive values, relative risks, and overall benefits of high and low maternal serum α-fetoprotein screening in singleton pregnancies: new epidemiologic data. Am J Obstet Gynecol 1989;161:291-7.
19. Williams MA, Hickok DE, Zingheim RW, Luthy DA et al. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes. Am J Obstet Gynecol 1992;167: 1032-7.
20. Hoffman ML, Scoccia B, Kurczynski TW, Shulman LP et al. Abnormal folate metabolism as a risk factor for first-trimester spontaneous abortion. J Reprod Med 2008 ;53:207-12.